119 related articles for article (PubMed ID: 10899658)
1. Macromolecule uptake in human melanoma xenografts. relationships to blood supply, vascular density, microvessel permeability and extracellular volume fraction.
Graff BA; Bjornaes I; Rofstad EK
Eur J Cancer; 2000 Jul; 36(11):1433-40. PubMed ID: 10899658
[TBL] [Abstract][Full Text] [Related]
2. Microvascular permeability of human melanoma xenografts to macromolecules: relationships to tumor volumetric growth rate, tumor angiogenesis, and VEGF expression.
Graff BA; Bjørnaes I; Rofstad EK
Microvasc Res; 2001 Mar; 61(2):187-98. PubMed ID: 11254398
[TBL] [Abstract][Full Text] [Related]
3. Transvascular and interstitial transport of a 19 kDa linear molecule in human melanoma xenografts measured by contrast-enhanced magnetic resonance imaging.
Bjørnaes I; Rofstad EK
J Magn Reson Imaging; 2001 Nov; 14(5):608-16. PubMed ID: 11747014
[TBL] [Abstract][Full Text] [Related]
4. Intratumour heterogeneity in the uptake of macromolecular therapeutic agents in human melanoma xenografts.
Graff BA; Kvinnsland Y; Skretting A; Rofstad EK
Br J Cancer; 2003 Jan; 88(2):291-7. PubMed ID: 12610516
[TBL] [Abstract][Full Text] [Related]
5. Quantitative assessment of uptake and distribution of iron oxide particles (NC100150) in human melanoma xenografts by contrast-enhanced MRI.
Graff BA; Vangberg L; Rofstad EK
Magn Reson Med; 2004 Apr; 51(4):727-35. PubMed ID: 15065245
[TBL] [Abstract][Full Text] [Related]
6. Microvascular permeability to macromolecules in human melanoma xenografts assessed by contrast-enhanced MRI--intertumor and intratumor heterogeneity.
Bjørnaes I; Rofstad EK
Magn Reson Imaging; 2001 Jun; 19(5):723-30. PubMed ID: 11672631
[TBL] [Abstract][Full Text] [Related]
7. Magnetic resonance imaging of human melanoma xenografts in vivo: proton spin-lattice and spin-spin relaxation times versus fractional tumour water content and fraction of necrotic tumour tissue.
Rofstad EK; Steinsland E; Kaalhus O; Chang YB; Høvik B; Lyng H
Int J Radiat Biol; 1994 Mar; 65(3):387-401. PubMed ID: 7908318
[TBL] [Abstract][Full Text] [Related]
8. PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
Rudin M; McSheehy PM; Allegrini PR; Rausch M; Baumann D; Becquet M; Brecht K; Brueggen J; Ferretti S; Schaeffer F; Schnell C; Wood J
NMR Biomed; 2005 Aug; 18(5):308-21. PubMed ID: 15918178
[TBL] [Abstract][Full Text] [Related]
9. Assessment of microvascular density, extracellular volume fraction, and radiobiological hypoxia in human melanoma xenografts by dynamic contrast-enhanced MRI.
Vestvik IK; Egeland TA; Gaustad JV; Mathiesen B; Rofstad EK
J Magn Reson Imaging; 2007 Oct; 26(4):1033-42. PubMed ID: 17896373
[TBL] [Abstract][Full Text] [Related]
10. Step-down heating of human melanoma xenografts: effects of the tumour microenvironment.
Rofstad EK
Br J Cancer; 1994 Sep; 70(3):453-8. PubMed ID: 8080730
[TBL] [Abstract][Full Text] [Related]
11. Melphalan uptake in relation to vascular and extracellular space of human lung-tumour xenografts.
Wist E; Millar JL; Shorthouse AJ
Br J Cancer; 1981 Apr; 43(4):458-63. PubMed ID: 6263305
[TBL] [Abstract][Full Text] [Related]
12. Intratumour heterogeneity in microvessel oxyhaemoglobin saturations.
Måseide K; Rofstad EK
Cancer Lett; 2001 Jan; 162(2):245-51. PubMed ID: 11146232
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of arterialized vein graft permeability with Evans blue dye and iodine 125-labeled albumin.
Finck SJ; Mashburn JP; Kottke BA; Orszulak TA
Ann Thorac Surg; 1989 Nov; 48(5):646-50. PubMed ID: 2818053
[TBL] [Abstract][Full Text] [Related]
14. Tumor growth modulation by sense and antisense vascular endothelial growth factor gene expression: effects on angiogenesis, vascular permeability, blood volume, blood flow, fluorodeoxyglucose uptake, and proliferation of human melanoma intracerebral xenografts.
Oku T; Tjuvajev JG; Miyagawa T; Sasajima T; Joshi A; Joshi R; Finn R; Claffey KP; Blasberg RG
Cancer Res; 1998 Sep; 58(18):4185-92. PubMed ID: 9751633
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the tumor vasculature and metastatic behavior of xenografts of human melanoma cell lines transfected with vascular permeability factor.
Pötgens AJ; van Altena MC; Lubsen NH; Ruiter DJ; de Waal RM
Am J Pathol; 1996 Apr; 148(4):1203-17. PubMed ID: 8644861
[TBL] [Abstract][Full Text] [Related]
16. Temporal and spatial changes in macromolecular uptake in rat thoracic aorta and relation to [3H]thymidine uptake.
Lin SJ; Jan KM; Chien S
Atherosclerosis; 1990 Dec; 85(2-3):229-38. PubMed ID: 2102086
[TBL] [Abstract][Full Text] [Related]
17. An in vivo assay to test blood vessel permeability.
Radu M; Chernoff J
J Vis Exp; 2013 Mar; (73):e50062. PubMed ID: 23524912
[TBL] [Abstract][Full Text] [Related]
18. Tumor-line specific causes of intertumor heterogeneity in blood supply in human melanoma xenografts.
Simonsen TG; Gaustad JV; Leinaas MN; Rofstad EK
Microvasc Res; 2013 Jan; 85():16-23. PubMed ID: 23149341
[TBL] [Abstract][Full Text] [Related]
19. 31P NMR spectroscopy studies of phospholipid metabolism in human melanoma xenograft lines differing in rate of tumour cell proliferation.
Lyng H; Olsen DR; Petersen SB; Rofstad EK
NMR Biomed; 1995 Apr; 8(2):65-71. PubMed ID: 7547188
[TBL] [Abstract][Full Text] [Related]
20. Blood flow in six human melanoma xenograft lines with different growth characteristics.
Lyng H; Skretting A; Rofstad EK
Cancer Res; 1992 Feb; 52(3):584-92. PubMed ID: 1732046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
